Skip to main content
Caplight Logo









NemaLife

NemaLife

Private
Lubbock, TexasHealthcare & Life Scienceshttps://www.nemalifeinc.com/

Last Round

Grant

Oct 22, 2024

Total Funding Raised

$1.37M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NemaLife is a TechBio company that develops AI-powered microfluidic solutions to accelerate the discovery and validation of functional ingredients for human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

high-throughput screeningdrug discoveryC. elegansphenotypic screeningmicrofluidicstoxicity testingcontract research organizationCROorganism-on-chippreclinical testinglab-on-a-chipphenotypic analysisdrug screeningAI-powered discoveryalternative to animal testingin vivo screeningbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NemaLife Comparables

Compare NemaLife with similar companies based on industry and business-model similarity.

NemaLife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
vivoVerse
93%
Nagi Bioscience SA
86%
InVivo Biosystems
86%

NemaLife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 22, 2024
GrantSep 27, 2022
GrantSep 13, 2022
StrategicMay 4, 2022

Key People

Founding team and executive leadership

MIZANUR RAHMAN

CTO & Co-founder

Founding Team

NemaLife Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 208% MoM, reaching 1.9K.

  • May 16, 2026

    Monthly visitors grew 49% MoM, reaching 1.2K.

NemaLife Filings

Explore SEC and related filing metadata, where available.

NemaLife filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NemaLife's valuation, stock price, and market status.

Is NemaLife a public or private company?

NemaLife is a private company.

What is the current stock price of NemaLife?

NemaLife is a private company with no public stock price. Caplight tracks NemaLife's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is NemaLife worth (valuation)?

Valuation information for NemaLife is not publicly available.

Can I buy NemaLife stock?

NemaLife shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NemaLife's last funding round?

NemaLife's most recent funding round was Grant on October 22, 2024.

Who are the main investors in NemaLife?

Key investors in NemaLife include Texas Tech Accelerator, NIH RADx, National Center for Complementary and Integrative Health, National Institute on Aging.

Will NemaLife IPO soon?

No public IPO plans have been announced for NemaLife.

How can I track NemaLife secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NemaLife's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLubbock, Texas
Employee Range21
Year Founded2019
Last FundingOct 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?